FeesSafety
Pluang+

Clarivate launches cash tender offers to buy back up to $500M of its 2028 and 2029 notes.

Company Fundamentals
04 Nov 2026, 16:19 WIB
PRNewsWire
View Source
Neutral
Clarivate launches cash tender offers to buy back up to $500M of its 2028 and 2029 notes.

Clarivate Plc announced that its subsidiary has started cash tender offers to repurchase up to $500 million of its outstanding 3.875% Senior Secured Notes due 2028 and 4.875% Senior Notes due 2029. The offer includes a $400 million cap for the 2028 notes and a $100 million cap for the 2029 notes, with the total consideration for the 2029 notes set at $928.75 per $1,000 principal. The tender offers expire on November 10, 2026, and are subject to conditions including proration and potential adjustments to the purchase caps. This move allows Clarivate to manage its debt profile and potentially reduce interest expenses.

Clarivate's debt repurchase offer provides context for financial markets, where breadth among 142 priced Financials-sector US stocks on Pluang showed 123 advancing and 19 declining as of Nov 04, 2026 20:12 WIB. Notable movers included RIOT at USD 16.96 with a 20.97% increase and a balanced Pluang order activity of 49% Sell / 51% Buy, UNM at USD 80.50 down 11.57%, and CLSK at USD 7.22 down 11.41% with strong buy interest at 82%.

More News

Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...

Market News
Bullish
36 minutes ago
Sutro Biopharma to present at multiple investor conferences in November and December 2026

Sutro Biopharma to present at multiple investor conferences in November and December 2026

Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...

Market News
Neutral
1 hour ago
etoro acquires Argentine fintech LB Finanzas to expand in Latin America

etoro acquires Argentine fintech LB Finanzas to expand in Latin America

etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...

Company Fundamentals
Bullish
1 hour ago
JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...

Company Fundamentals
Neutral
4 hours ago
KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App